study group | Q673899 |
Q36219778 | Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men. |
Q46546975 | Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study |
Q50761727 | Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. |
Q38633892 | Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease |
Q40485808 | Effect of HIV-infection and cumulative viral load on age-related decline in grip strength |
Q38675041 | Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study |
Q34813982 | Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence |
Q33939861 | Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis |
Q35159533 | Factors affecting brain structure in men with HIV disease in the post-HAART era. |
Q79827410 | HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty |
Q44933768 | HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). |
Q57446072 | HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998 |
Q36462095 | Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men |
Q46050796 | Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals |
Q46520858 | Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection |
Q37235079 | Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. |
Q34862412 | Subcortical brain atrophy persists even in HAART-regulated HIV disease |
Q39557004 | Therapy naivete in the era of potent antiretroviral therapy |
Q37393465 | Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. |
Search more.